Dinja T Kruger (Dinja Kruger)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum

Positive Breast Cancer

Replacement Therapy

Binding Protein

Top Venues

The Journal of experimental medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja T Kruger, Onno B Bleijerveld, Chiara S Brambillasca, Justin Sprengers, Bjorn Siteur, Stefano Annunziato, Matthijs J van Haren, Nathaniel I Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C Linn, Epie Boven, A F Maarten Altelaar, Jos Jonkers, Daniel Zingg, Lodewyk F A Wessels
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. The Journal of experimental medicine 220 (11) (2023)
Dinja T Kruger, Xanthippi Alexi, Mark Opdam, Karianne Schuurman, Leonie Voorwerk, Joyce Sanders, Vincent van der Noort, Epie Boven, Wilbert Zwart, Sabine C Linn
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer. International journal of cancer 146 (8) (2019)